There is provided a combination product comprising; (A) melagatran or a pharmaceutically acceptable derivative thereof; and (B) dexamethasone or a pharmaceutically acceptable derivative there of, wherein each of components (A) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier, as well as the use of such a combination product in the treatment of conditions including disseminated intravascular coagulation.

 
Web www.patentalert.com

< Anti-HER2 antibody variants

> Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use

~ 00474